Robust efficacy of BLU-285, a novel, potent inhibitor of exon 17 mutant KIT and PDGFRA p.D842V,in a patient-derived xenograft model of gastrointestinal stromal tumor (GIST)

Abstract

status: publishe

    Similar works

    Full text

    thumbnail-image

    Available Versions